Winners & Losers
Thursday's Health Winners & Losers
05/01/08 - 02:58 PM EDT
And Advanced Medical Optics EYE said its first-quarter net profit was $6.9 million, or 11 cents a share, down from $12.1 million, or 20 cents a share, a year earlier. Factoring out acquisition and restructuring charges, the company earned 22 cents a share, on net sales to $303.7 million. Analysts surveyed by Thomson Financial were looking for 22 cents a share, on revenue of $294.6 million. Shares rose 11.9% to $23.50. Heading the other direction, laser device company Palomar Technologies PMTI found its shares down 16.7% at $11.75, after reporting a net loss of $1 million, or 5 cents a share, vs. a profit of $5.9 million, or 30 cents a share, a year earlier. On an adjusted basis, the company earned 9 cents a share on revenue of $23 million, which was down from $31.5 million in 2007. Analysts surveyed by Thomson Financial were looking for 7 cents a share on revenue of $28.7 million. Medical technology company Hologix HOLX, which recently completed a 2-for-1 stock split, plummeted $6.02, or 20.1%, to $23.17 Thursday after the company aired its second-quarter results. Revenue climbed to $431 million from $181.1 million. Hologic reported net income of $56 million, or 22 cents a share a share -- and adjusted profit of $76.2 million, vs. $24 million a year prior. Analysts surveyed by Thomson Financial were looking for $70.6 million, and 28 cents a share, on revenue of $418 million.
BioMarin climbs higher after swinging to a profit and beating Wall Street estimates for the first quarter.
FDA rejection hits Merck shares.
Regulatory delays send Medarex to a new 52-week low.
These forgotten Internet stocks are being accumulated by hedge funds.
Raspberries for Apple; You'll be sorry, UBS; Fortress or Fort Knox? Wholly unappetizing Foods; give Liberty AOL or give them...
The GOP presidential candidate raised $27 million in July.
Some credit and debit cards give you some cash back on purchases. But you need to manage it well to benefit from it.
Sponsored by:




